Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE leaders discuss national priorities, sustainable development
UAE issues warning over heavy fog conditions
Kazakhstan takes top spot on day four of UAE SWAT Challenge
UAE, Finland Presidents review ties, regional developments
Dubai announces new desert eco-tourism destination
First aid batch from Saqr Humanitarian Ship enters Gaza
Abu Dhabi launches community-funded building to raise money for scholarships
UAE, Iran hold political consultations in Tehran
Dubai records new tourism milestones
UAE Floating Hospital in Egypt's Al Arish opens dialysis unit
UAE launches device to increase organ donation survival rates
H.H. Sheikh Mohammed opens World Health Expo Dubai
Dubai Press Club reveals expanded programme for Arab Media Summit
UAE condemns attack on WFP aid convoy in Sudan
UAE and Egypt Presidents hold talks in Abu Dhabi
UAE joins 7 nations in condemning Israel for expanding control over West Bank
UAE welcomes US comprehensive peace plan for Sudan
UAE President congratulates Japan's Takaichi on historic win
UAE issues special coins to mark 5 years of MBZUAI
Abu Dhabi expands robotaxi services to more neighbourhoods
